BioIndustry Association

According to its website:

The BIA exists to promote the human health benefits of new bioscience technologies, encouraging the commercial success of the bioscience industry by focusing on emerging enterprise and the related interests of companies with whom such enterprise trades.

The BIA supports member interests by lobbying Government and Parliament in the UK and Brussels, providing high quality information and business services, and attracting investment from both private and Government sources.^[1]

People

Board Members

• Dr. Simon Best Chairman, BIA (2006)
• Ms Aisling Burnand Chief Executive, BIA
• Ms Jane Osbourn will serve as the new chair from January 2016.

Corporate Members - from January 2006

Mr Glyn Edwards - Antisoma Dr Steve Chatfield - Emergent Dr Andrew Heath - Protherics Dr Roland Kozlowski - Lectus Therapeutics Mr Ian Nicholson - Chroma Therapeutics Mr Peter Nolan - Oxford BioMedica Dr David Chiswell - Sosei Co. see Sosei Group Dr Andy Richards - Vectura Mr Simon Sturge - Vernalis Dr Jeremy Haigh - Amgen

Associate Members - from January 2006

Ms Kate Bingham - SLV Life Sciences Mr Geoff Newman - InteRea International Mr David Porter - Mizuho

Related people

• Tracey Brown
• John Hillman
• David Sainsbury
• Bill Macfarlane Smith
• Paul Drayson Chair 2001-2

PR and Lobbying firms

• Regester Larkin
• PLMR
• Blue Rubicon

Members at March 2007

3i plc | Abcellute | Abingworth Management Ltd | Acambis plc | Advanced Centre for Biochemical Engineering | Advent Venture Partners | Aggio Partners Limited | Alan Boyd Consultants Ltd | Alba Biosciences | Alice Ventures | Alizyme Therapeutics Ltd | Amarin Corporation plc | Amgen Ltd | Andrew Sheard Patent Practice | Angel Biotechnology | Animal Health Technology Complex | Ann J Simon | Antisoma plc | Antoxis | Apax Partners | Apex Healthcare Consulting Ltd | Aptuit | Aquapharm Bio-Discovery Ltd | Archimedes Pharma Ltd | Ardana BioScience Limited | Arecor Ltd | Ark Therapeutics | Arnold & Porter | Ashurst | Asterand UK Ltd | Astex Technology | Atlas Ventures | Avecia Biologics | Avesthagen Technologies | Avidex/MediGene | Avlar BioVentures Limited | Babraham Bioscience Technologies Ltd | Baker & McKenzie | Barclays Bank | Barlow Lyde & Gilbert | BBSRC | BCG Europe | BDKT Lifescience Facilities | Bench International | Biggart Baillie | BIO | Bio Products Laboratory | BioApproaches South West | BioBridge | Biocatalysts Ltd | BioCity Ltd | Biocompatibles International plc | BioDundee | Biogen Idec Ltd | BioInvent | BioMed Research Consulting Ltd | BioPark Hertfordshire Ltd | BioPartners Ltd | BioPharm Services Limited | BioRad Europe | BioReliance Ltd | BioScience Managers | BioScience York | Biotica | Bird & Bird | Blake Lapthorn Linnell | Bodiam Consulting Limited | Borders Technology | Bridgehead International Ltd | Bristows | Brown Rudnick | Bryan Cave | BTG | Buchanan Communications | Business Therapies | Cambridge Antibody Technology Group plc | Cambridge Biostability Ltd | Cambridge Research Biochemicals Ltd | Cambridge University Challenge Fund | Cancer Research Techology Ltd | Carole Barbone | Cascade Technologies | CEL International Ltd | CellCentric Ltd | CellData Services | Celldex Therapeutics Ltd | Celliance | Celltech Group plc | Cellzome (UK) Ltd | CELS Ltd | Centre for Enterprise Management | Cephalon - Europe | Charles Kendall Freight Limited | Charles River Laboratories | Charles Russell | Chiron Vaccines | Chroma Therapeutics Ltd | Chubb Insurance Company of Europe, SA. | Citigate Dewe Rogerson | CMC Biopharmaceuticals | CMP Therapeutics Ltd | CMS Cameron McKenna | Cobra Bio-Manufacturing | Code Securities Ltd | Cognia EU Ltd | Controlled Therapeutics | Coulter Partners | Covance | Covington & Burling LLP | CRC Phase I/ll Clinical Trials Committee Formulation Unit | Critical I | CXR Biosciences Ltd | Cyclacel Ltd | D Young and Co | DB Technologies Ltd | De Facto Communications | Deloitte & Touche | Denton Wilde Sapte | DLA | Domantis Ltd | Dundas & Wilson | E-Scape Recruitment Services Ltd | Eastern Region Biotechnology | Eden Biodesign Ltd | Eden Scott | Edinburgh Research and Innovation | Egon Zehnder International | EiRx Therapeutics plc | Emergent Product Development UK Ltd | Encap Drug Delivery | Endpoint Research UK Ltd | Enigma Diagnostics Ltd | ENKAM Pharmaceuticals A/S | Eric Potter Clarkson LLP | Ernst & Young | Ethicon Ltd | European Bioinformatics Institute | Eversheds | Evolution Securities Limited | Exmoor Pharma Concepts Ltd | Ferring Research Ltd | Financial Dynamics | Freshfields Bruckhaus Deringer | Fulcrum Pharma Developments Ltd | Fusion Antibodies Ltd | GE Healthcare | Genecom | GeneMedix plc | Genesis Faraday | Genetrix SL | Genzyme Ltd | Gilead Sciences Ltd | Giles Insurance Brokers Ltd | Gillies O'Bryan -Tear | Global Open | Glycoform Ltd | Government of Western Australia - European Office | Grant Thornton | Gregory Fryer Associates Ltd | GlaxoSmithKline | Hannah Cell Science | Hannah Research Institute | Haptogen | Health Protection Agency | Herbert Smith | Hewitsons | Hilary Newiss | Hindle Lowther | Hogarth Partnership | Hugo Schepens | Hunter Fleming Ltd | Huntingdon Life Sciences | IBM UK Ltd | IDIS | Imperial Innovations plc | Innovata plc | Intercell Biomedical Ltd | Intercytex Ltd | Interea International Ltd | International Business Wales | Intertek ASG | Invermay Consulting | Investec Securities | ITI Life Sciences | J S Associates | J A Kemp and Co | James Cowper | Jeremy Curnock Cook | John Aston | KCL Enterprises | Kilburn and Strode | Kirkland and Ellis International | Korn/ Ferry International | Kryotrans Limited | LE Executive Resourcing | Lectus Therapeutics Ltd | LGC | Linklaters | London Biotechnology Network | London Technology Network | Lonza Biologics plc | Lovells | Maclay Murray and Spens | Malaria Foundation | Management Forum Ltd | Manches | Marks and Clerk Scotland | Martineau Johnson | Mayer, Brown, Rowe and Maw | McGrigors | Media Speak | Medical Research Council Technology | Melville Craig | Merlin Biosciences Limited | MerseyBIO | Millipore | Mills & Reeve | Mizuho International plc | MNLpharma Ltd | Moredun Research Institute | Morgan Stanley | Morrison & Foerster MNP | Morvus Technology Ltd | Murgitroyd and Company | Mylnefield Research Services Ltd | National Institute for Biological Standards Control | neuropharm | New Bridge Street Consultants | Nexxus | Nomura International plc | Nomura Phase4 Ventures | North West Development Agency - BioNow | Northbank Communications | NovaBiotics Ltd | Novozymes Delta Ltd | NPL Management Limited | Olswang | Onyvax Ltd | Osborne Clarke | Oxagen Ltd | Oxford BioMedica plc | Oxford Genome Sciences (UK) Ltd | Oxford Therapeutics Consulting Ltd | Oxfordshire Bioscience Network | Pan Diagnostics | PanGenetics BV | Paradigm Therapeutics Ltd | Partnerships UK PLC | Paul Capital Advisors UK Ltd | Paul Pattinson | People in Health Ltd | Pfizer Global Research and Development | PharmaKodex | Physiomics plc | PhytoPharm | Piper Jaffray Ltd | PIramed Ltd | Ploughshare Innovations | PricewaterhouseCoopers LLP | ProPharma | ProPharma Partners | Prosidion Ltd | ProStrakan | Protherics | Proxima Concepts Ltd | Qiagen | QuA Vodis Ltd | Quadrant Drug Delivery Ltd | Quest Management | Quester Capital Management Ltd | Quintiles Limited | Quintiles Ltd | Rapisardi Intellectual Property Ltd | Reed Smith | Reneuron Ltd | Robin Nott | Roslin Institute | Rowett Research Services Ltd | RSA | Ruston Poole International plc | Sareum Ltd | Schroder Ventures Life Sciences Advisers (UK) Ltd | Scottish Association for Marine Life | Scottish Biomedical | Scottish Centre for Genomic Technology and Informatics (SCGTI) | Scottish Crop Research Institute | Scottish Enterprise Life Sciences | Scottish Equity Partners | Scottish Health Innovations | SEEDA | Serologicals Ltd | Shepherd and Wedderburn | Shire Pharmaceuticals Group plc | Simmons and Simmons | SJ Berwin | Slaughter and May | SmartBead Technologies Ltd | SNBTS | Snedden Campbell | Sosei Co. Ltd. see Sosei Group | SR Pharma | Stedim | Stem Cell Sciences plc | Stirling Medical Innovations Ltd | Stratagem Intellectual Property Management Ltd | Stringer Saul | Sudbrook Associates LLP | SUIP Ltd | Synaptech Consultants Ltd | Syntaxin Ltd | Talentmark | Targeting Innovation Ltd | Taylor Consulting | Taylor Vinters | Taylor Wessing | The Ann Hayes Consultancy Ltd | The Government of Victoria - Australia | The Institute of Cancer Research | The Ness Foundation | The Wellcome Trust | Thiakis Ltd | TMX Risk Solutions | Tods Murray LLP | TopoTarget UK Ltd | Trigen Ltd | Tsquared | Tukan Partners Ltd | UCL BioMedica Plc | UMIC | University of Aberdeen | University of Dundee | University of Glasgow | University of Leicester | University of Nottingham | University of Sheffield | University of Southampton | University of St Andrews | University of Strathclyde | Upstate | Vectura Group plc | VeriCore Limited | Vernalis plc | Vertex Pharmaceuticals (Europe) Ltd | Viragen (Scotland) Ltd | Willoughby and Partners | Withers & Rogers | Wood Mackenzie Ltd | Wragge and Co LLP | Wright, Johnston and Mackenzie LLP | Xenova Group plc | XtruTex Ltd | YM BioSciences Inc. | Yorkshire Forward | Zeneus Pharma Ltd | Zyentia Ltd